Healthcare And Biotechnology

Content related to: Healthcare and Biotechnology

Does the Medicare Advantage Announcement Make Healthcare Stocks a Buy?

Friday, April 12th, 2013
by Jason Jenkins

The Picks and Shovels (and Levi’s) of Biotech

Wednesday, February 27th, 2013
by Marc Lichtenfeld

PDUFA Dates: How to Find One Day Gains of Up to 74%

Wednesday, February 13th, 2013
by Marc Lichtenfeld

The Business of Fighting Cancer

Wednesday, February 6th, 2013
by Marc Lichtenfeld

Regeneron (Nasdaq: REGN): Have You Missed the Boat?

Wednesday, January 30th, 2013
by Jason Jenkins

5 Rules for Speculating in Biotech

Wednesday, January 30th, 2013
by Marc Lichtenfeld

Ignore the Smartest Guys in the Room, All 8,600 of Them

Wednesday, January 9th, 2013
by Marc Lichtenfeld

Three Keys to Investing in Biotech Stocks

Wednesday, September 26th, 2012
by Marc Lichtenfeld

OPK: Why an Insider is plowing $17 Million into This Stock

Monday, August 27th, 2012
by Mike Kapsch

Investing in Drug-Resistant Antibiotics

Monday, August 13th, 2012
by Steve McDonald

« Previous Entries

Check out our selection of daily Investment Research:

Investment U Disclaimer: Nothing published by Investment U should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Investment U should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Popular

Recent

Categories